BRPI0908143A2 - Agente de branqueamento e preparação externa da pele - Google Patents

Agente de branqueamento e preparação externa da pele

Info

Publication number
BRPI0908143A2
BRPI0908143A2 BRPI0908143-7A BRPI0908143A BRPI0908143A2 BR PI0908143 A2 BRPI0908143 A2 BR PI0908143A2 BR PI0908143 A BRPI0908143 A BR PI0908143A BR PI0908143 A2 BRPI0908143 A2 BR PI0908143A2
Authority
BR
Brazil
Prior art keywords
bleaching agent
external skin
skin preparation
preparation
external
Prior art date
Application number
BRPI0908143-7A
Other languages
English (en)
Inventor
Naoto Hanyu
Tomoko Saito
Takako Shibata
Kiyoshi Sato
Kimihiro Ogino
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40952264&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0908143(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of BRPI0908143A2 publication Critical patent/BRPI0908143A2/pt
Publication of BRPI0908143B1 publication Critical patent/BRPI0908143B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0908143A 2008-02-08 2009-02-06 'agente de branqueamento e preparação para uso externo na pele". BRPI0908143B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008029106 2008-02-08
JP2008199606 2008-08-01
PCT/JP2009/052076 WO2009099192A1 (ja) 2008-02-08 2009-02-06 美白剤及び皮膚外用剤

Publications (2)

Publication Number Publication Date
BRPI0908143A2 true BRPI0908143A2 (pt) 2015-08-11
BRPI0908143B1 BRPI0908143B1 (pt) 2016-12-20

Family

ID=40952264

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908143A BRPI0908143B1 (pt) 2008-02-08 2009-02-06 'agente de branqueamento e preparação para uso externo na pele".

Country Status (11)

Country Link
US (6) US20100316584A1 (pt)
EP (5) EP2250999B1 (pt)
JP (4) JP4613248B2 (pt)
KR (4) KR101102640B1 (pt)
CN (4) CN101965177A (pt)
AU (1) AU2009211564B2 (pt)
BR (1) BRPI0908143B1 (pt)
ES (4) ES2655305T3 (pt)
RU (1) RU2434634C1 (pt)
TW (4) TWI353246B (pt)
WO (4) WO2009099194A1 (pt)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009099194A1 (ja) * 2008-02-08 2009-08-13 Shiseido Company Ltd. 美白剤及び皮膚外用剤
AR077999A1 (es) 2009-09-02 2011-10-05 Vifor Int Ag Antagonistas de pirimidin y triazin-hepcidina
DE102010002558A1 (de) * 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
JP5164179B2 (ja) * 2009-12-28 2013-03-13 株式会社 資生堂 液状化粧料
KR101186021B1 (ko) 2010-01-18 2012-09-26 가부시키가이샤 시세이도 피리미디닐피라졸 화합물의 제조방법
JP5693862B2 (ja) * 2010-02-24 2015-04-01 株式会社 資生堂 美白日焼け止め化粧料
CA2792503A1 (en) * 2010-03-10 2011-09-15 Galleon Pharmaceuticals, Inc. Analgesic compounds, compositions, and uses thereof
DE102010012594A1 (de) * 2010-03-23 2011-09-29 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an einem oder mehreren Thiazolderivaten
JP2013523721A (ja) * 2010-03-31 2013-06-17 株式會社アモーレパシフィック メラニン色素生成抑制剤及びこれを含有する化粧料組成物
WO2012124436A1 (ja) * 2011-03-17 2012-09-20 株式会社 資生堂 皮膚化粧料
TWI566772B (zh) * 2011-04-12 2017-01-21 資生堂股份有限公司 美白劑及黑色素生成抑制劑
DE102011083283A1 (de) 2011-09-23 2013-03-28 Beiersdorf Ag Heteroalkylamidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Heteroalkylamidothiazolen
DE102011083271A1 (de) * 2011-09-23 2013-03-28 Beiersdorf Ag Aromatische Amidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Aromatischen Amidothiazolen
DE102011083259A1 (de) * 2011-09-23 2013-03-28 Beiersdorf Ag Alkylamidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Alkylamidothiazolen
JP2015523333A (ja) * 2012-05-16 2015-08-13 コシードバイオファーム カンパニー リミテッド 魚類眼球の破砕物又は抽出物を含有する化粧料、薬学及び食品組成物
DE102013204097A1 (de) 2013-03-11 2014-10-30 Beiersdorf Ag Wirkstoffkombinationen aus Alkylamidothiazolen und einer oder mehreren kosmetisch oder dermatologisch unbedenklichen UV-Filtersubstanzen
DE102013204081A1 (de) 2013-03-11 2014-09-11 Beiersdorf Ag Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch unbedenklichen Konservierungsmitteln
DE102013204088A1 (de) 2013-03-11 2014-09-11 Beiersdorf Ag Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch relevanten Duftstoffen
DE102013204110A1 (de) 2013-03-11 2014-09-25 Beiersdorf Ag Wirkstoffkombinationen aus Alkylamidothiazolen und einem oder mehreren Cyclodextrinen
DE102013204070A1 (de) 2013-03-11 2014-09-11 Beiersdorf Ag Verwendung kosmetisch oder dermatologisch unbedenklicher substituierter Michael-Akzeptoren zur Verhinderung, Verminderung oder Prophylaxe der Tyrosinaseaktivität der menschlichen Haut und/oder deren Aufhellung
JP6522602B2 (ja) 2013-07-02 2019-05-29 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Ｒｏｃｋ阻害剤としての三環式ピリド−カルボキサミド誘導体
TW201506024A (zh) 2013-07-02 2015-02-16 必治妥美雅史谷比公司 作為有效ｒｏｃｋ抑制劑的三環甲醯胺衍生物
CN103822976B (zh) * 2013-10-15 2015-05-27 辽宁省食品药品检验所 一种测定化妆品中4-甲氧基水杨酸钾的方法
RU2680403C1 (ru) * 2013-11-29 2019-02-21 ЭмТиДжи КО., ЛТД. Водное средство ухода за кожей
LT3177612T (lt) 2014-08-04 2022-06-10 Nuevolution A/S Pirimidino dariniai, pakeisti pasirinktinai kondensuotu heterociklilu, tinkami uždegiminių, metabolinių, onkologinių ir autoimuninių ligų gydymui
DE102014223570A1 (de) * 2014-11-19 2016-05-19 Beiersdorf Ag Zubereitungen mit einem Gehalt an Ascorbinsäure, Ubidecarenon und Phosphationen zur verbesserten Hautkonturierung bzw. gegen Cellulite
EP3259256B1 (en) * 2015-02-17 2022-03-09 Beijing Erai Therapeutics Co., Ltd. Compounds and methods for inducing browning of white adipose tissue
WO2016202935A1 (en) 2015-06-19 2016-12-22 Bayer Pharma Aktiengesellschaft Glucose transport inhibitors
AU2017275657B2 (en) 2016-06-02 2021-08-19 Novartis Ag Potassium channel modulators
CN109414388B (zh) * 2016-07-14 2022-03-22 昭和电工株式会社 乳清酸衍生物或其盐的用途
UA123810C2 (uk) 2017-01-23 2021-06-02 Цадент Терапеутікс, Інк. Модулятори калієвих каналів
JP7731064B2 (ja) 2017-04-19 2025-08-29 御木本製薬株式会社 トラネキサム酸類配合製剤
JP7231617B2 (ja) 2017-08-31 2023-03-01 ビーエーエスエフ ソシエタス・ヨーロピア 生理学的冷涼活性成分の使用、及びそのような活性成分を含む組成物
CN108929271B (zh) * 2018-06-29 2021-08-31 中国药科大学 酪氨酸酶抑制剂及其制备方法与用途
MX2021004647A (es) 2018-10-22 2021-08-16 Novartis Ag Formas cristalinas de moduladores de los canales de potasio.
CN109758379A (zh) * 2019-03-20 2019-05-17 广州纳丽生物科技有限公司 一种复方凝血酸组合物及其制备方法、产品
JP2021100925A (ja) * 2019-10-31 2021-07-08 共栄化学工業株式会社 皮膚外用剤
MX2022007265A (es) 2019-12-20 2022-09-09 Nuevolution As Compuestos activos frente a receptores nucleares.
TWI872177B (zh) 2019-12-20 2025-02-11 丹麥商紐韋盧森公司 對核受體具有活性之化合物
US11613532B2 (en) 2020-03-31 2023-03-28 Nuevolution A/S Compounds active towards nuclear receptors
JP7824032B2 (ja) * 2020-03-31 2026-03-04 株式会社コーセーホールディングス 組成物
US11780843B2 (en) 2020-03-31 2023-10-10 Nuevolution A/S Compounds active towards nuclear receptors
CN112675076A (zh) * 2021-01-04 2021-04-20 上海新高姿化妆品有限公司 一种提亮肤色的化妆品组合物及其制备方法与应用
CN117545456A (zh) * 2021-07-21 2024-02-09 株式会社资生堂 皮肤渗透用化妆料和皮肤渗透用化妆料的制造方法
DE102022209937A1 (de) 2022-09-21 2024-03-21 Beiersdorf Aktiengesellschaft Wirkstoffkombinationen aus Alkylamidothiazolen und einem oder mehreren Biopolymeren
CN115991698B (zh) * 2022-11-03 2024-03-29 广东中科药物研究有限公司 一种杂环化合物及其制备方法与应用
JP2024089769A (ja) * 2022-12-22 2024-07-04 株式会社 資生堂 化粧料
WO2024135395A1 (ja) 2022-12-22 2024-06-27 株式会社 資生堂 化粧料
CN120265266A (zh) * 2022-12-26 2025-07-04 株式会社资生堂 化妆料
KR102852940B1 (ko) * 2023-01-20 2025-08-29 대전대학교 산학협력단 1,3-디옥틸옥시벤젠을 유효성분으로 포함하는 피부 미백용 조성물
DE102023210909A1 (de) 2023-11-03 2025-05-08 Beiersdorf Aktiengesellschaft Wirkstoffkombinationen aus Alkylamidothiazolen und einem oder mehreren aliphatischen verzweigten oder unverzweigten Aldehyden
DE102023210912A1 (de) 2023-11-03 2025-05-08 Beiersdorf Aktiengesellschaft Wirkstoffkombinationen aus Alkylamidothiazolen und Ethylmaltol
DE102023210907A1 (de) 2023-11-03 2025-05-08 Beiersdorf Aktiengesellschaft Wirkstoffkombinationen aus Alkylamidothiazolen und delta-Decalacton
DE102023210917A1 (de) 2023-11-03 2025-05-08 Beiersdorf Aktiengesellschaft Wirkstoffkombinationen aus Alkylamidothiazolen und Isobutylchinolin
DE102023210906A1 (de) 2023-11-03 2025-05-08 Beiersdorf Aktiengesellschaft Wirkstoffkombinationen aus Alkylamidothiazolen und Indol
DE102023210919A1 (de) 2023-11-03 2025-05-08 Beiersdorf Aktiengesellschaft Wirkstoffkombinationen aus Alkylamidothiazolen und Gamma-Undecalacton
DE102023211235A1 (de) 2023-11-13 2025-05-15 Beiersdorf Aktiengesellschaft Wirkstoffkombinationen aus Alkylamidothiazolen und Ölkomponenten
WO2025110033A1 (ja) * 2023-11-24 2025-05-30 株式会社 資生堂 化粧料
WO2025115637A1 (ja) * 2023-11-28 2025-06-05 株式会社 資生堂 化粧料
WO2025134805A1 (ja) * 2023-12-22 2025-06-26 株式会社資生堂 化粧料
WO2025142473A1 (ja) * 2023-12-25 2025-07-03 株式会社資生堂 化粧料

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54117029A (en) 1978-02-28 1979-09-11 Hokko Chem Ind Co Ltd Agricultural and horticultural microbicide
JPS6059883B2 (ja) 1978-05-08 1985-12-27 北興化学工業株式会社 農園芸用殺菌剤
JPS62404A (ja) 1985-06-25 1987-01-06 Takeda Chem Ind Ltd 農業用殺菌剤
EP0234104B1 (en) * 1985-12-03 1990-10-24 Sumitomo Chemical Company, Limited Novel pyridinylpyrimidine derivatives, method for production thereof and a plant disease protectant containing them as the active ingredient
ZA868951B (en) * 1985-12-07 1987-08-26 Shionogi & Company Limited Organophosphorus compounds having pesticidal activity
EP0264883A3 (en) * 1986-10-21 1990-04-04 Banyu Pharmaceutical Co., Ltd. Substituted pyridine derivatives
EP0278610A3 (en) * 1987-02-13 1990-03-14 Sumitomo Chemical Company, Limited Novel pyridinyl-s-triazine derivatives, method for production thereof and a fungicide containing them as the active ingredient
US5332627A (en) * 1990-10-30 1994-07-26 Sony Corporation Field emission type emitter and a method of manufacturing thereof
JP3033178B2 (ja) 1990-10-30 2000-04-17 ソニー株式会社 電界放出型エミッタ
JP2997071B2 (ja) 1991-01-11 2000-01-11 和彦 石井 痔疾治療剤
JP2680771B2 (ja) 1992-06-17 1997-11-19 大建工業株式会社 無機質下地板
JP2710088B2 (ja) * 1992-07-03 1998-02-10 宇部興産株式会社 ポリフッ化チアゾリン誘導体、その製法及び有害生物防除剤
JP3154834B2 (ja) * 1992-10-23 2001-04-09 第一製薬株式会社 チロシナーゼ阻害剤
JP3023178B2 (ja) 1994-11-29 2000-03-21 久光製薬株式会社 ２−アミノチアゾール誘導体およびその塩類からなる抗菌剤または殺菌剤
JPH08208620A (ja) 1995-02-03 1996-08-13 Takeda Chem Ind Ltd アミノピラゾール誘導体、その製造法および用途
JPH08231520A (ja) * 1995-02-28 1996-09-10 Showa Sangyo Co Ltd チロシナーゼ阻害剤
US5883254A (en) * 1996-11-08 1999-03-16 Hoffmann-La Roche Inc. Process for making pyrimidine derivatives
FR2768618B1 (fr) * 1997-09-23 1999-10-22 Oreal Composition de teinture d'oxydation des fibres keratiniques et procede de teinture mettant en oeuvre cette composition
FR2769221B1 (fr) * 1997-10-03 2000-01-14 Oreal Composition oxydante et utilisations pour la teinture, pour la deformation permanente ou pour la decoloration des fibres keratiniques
DE10008907A1 (de) * 2000-02-25 2001-08-30 Haarmann & Reimer Gmbh Topische kosmetische Mittel enthaltend benzokondensierte oder heterocyclisch kondensierte 2-Hydrazino-1,3-heteroazole
AU778128B2 (en) * 2000-04-19 2004-11-18 Nof Corporation Cosmetic composition
DE10111050A1 (de) 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigenOrganismus ihre Wirkung entfaltet, zur Herstellung von kosmetischewn oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe unerwünschter Hautpigmentierung
US20040209924A1 (en) * 2001-09-26 2004-10-21 Barry Hart Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors
WO2003027101A1 (en) 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors
US20040198773A1 (en) * 2001-09-26 2004-10-07 Barry Hart Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors
US20040267017A1 (en) * 2001-09-26 2004-12-30 Bierer Donald E 3-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitors
US20040236110A1 (en) * 2001-09-26 2004-11-25 Ladouceur Gaetan H Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
EP1437348A1 (fr) 2003-01-13 2004-07-14 L'oreal Dérivés de de la 6-méthyl-pyrimidine-2,4-diamine, procédé de synthèse, compositions les comprenant et utilisations comme agents neutralisants basiques
EP1594438B1 (fr) * 2003-02-12 2013-07-17 L'Oréal Utilisation d'un inhibiteur de 15-hydroxy prostaglandine déshydrogénase pour favoriser la pigmentation de la peau ou des phanères
ATE410161T1 (de) 2003-05-02 2008-10-15 Elan Pharm Inc 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3- carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen
KR20060054308A (ko) 2003-07-16 2006-05-22 가부시키가이샤 이야쿠 분지 셋케이 겐쿠쇼 피부 색소침착의 치료제
WO2005028467A1 (en) * 2003-09-15 2005-03-31 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds
US20090036475A1 (en) 2005-03-22 2009-02-05 Neurosearch A/S Pyrazolyl-Pyrimidines as Potassium Channel Modulating Agents and Their Medical Use
JP2008534472A (ja) * 2005-03-22 2008-08-28 ノイロサーチ アクティーゼルスカブ カリウムチャンネル調節剤としてのピラゾリル−ピリミジン及びその医学的使用
FR2885128B1 (fr) * 2005-04-27 2007-07-06 Expanscience Laboratoires Sa Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant
CA2612287C (en) * 2005-06-15 2011-01-25 Pfizer Limited Substituted arylpyrazoles for use against parasites
WO2006133876A1 (en) * 2005-06-17 2006-12-21 Dsm Ip Assets B.V. Use of pyrimidine derivatives for cosmetic purposes
KR100716891B1 (ko) * 2005-11-01 2007-05-09 (주)아모레퍼시픽 피리딘 티아졸 카복사마이드 유도체, 이의 제조방법 및이를 함유하는 피부 미백용 조성물
US20070243132A1 (en) * 2005-12-22 2007-10-18 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents
WO2009099194A1 (ja) * 2008-02-08 2009-08-13 Shiseido Company Ltd. 美白剤及び皮膚外用剤

Also Published As

Publication number Publication date
US8211412B2 (en) 2012-07-03
EP2251000B1 (en) 2016-04-13
CN101938988B (zh) 2013-06-19
RU2434634C1 (ru) 2011-11-27
JPWO2009099195A1 (ja) 2011-05-26
US20130045173A1 (en) 2013-02-21
JP4665052B2 (ja) 2011-04-06
HK1149487A1 (en) 2011-10-07
CN101965176B (zh) 2012-06-20
CN101965176A (zh) 2011-02-02
JP4592820B2 (ja) 2010-12-08
WO2009099195A1 (ja) 2009-08-13
CN101965177A (zh) 2011-02-02
EP2250998A4 (en) 2011-05-11
KR101102640B1 (ko) 2012-01-04
KR20100111293A (ko) 2010-10-14
WO2009099194A1 (ja) 2009-08-13
JPWO2009099193A1 (ja) 2011-05-26
US20110003838A1 (en) 2011-01-06
ES2655305T3 (es) 2018-02-19
US20100324096A1 (en) 2010-12-23
HK1149488A1 (en) 2011-10-07
WO2009099193A1 (ja) 2009-08-13
CN101938988A (zh) 2011-01-05
BRPI0908143B1 (pt) 2016-12-20
ES2582228T3 (es) 2016-09-09
ES2582176T3 (es) 2016-09-09
KR101037515B1 (ko) 2011-05-26
TWI353246B (en) 2011-12-01
JP4613248B2 (ja) 2011-01-12
EP2250998A1 (en) 2010-11-17
JPWO2009099192A1 (ja) 2011-05-26
TW200938228A (en) 2009-09-16
HK1150757A1 (en) 2012-01-13
AU2009211564A1 (en) 2009-08-13
EP2251001A4 (en) 2013-01-09
EP2251000A1 (en) 2010-11-17
KR20100121617A (ko) 2010-11-18
EP2250999B1 (en) 2016-04-13
TW200938227A (en) 2009-09-16
EP2250999A1 (en) 2010-11-17
JP4586108B2 (ja) 2010-11-24
KR20100121618A (ko) 2010-11-18
AU2009211564B2 (en) 2013-08-29
TWI348920B (en) 2011-09-21
ES2582227T3 (es) 2016-09-09
CN101938989A (zh) 2011-01-05
EP2251001A1 (en) 2010-11-17
US8324234B2 (en) 2012-12-04
EP2251000A4 (en) 2011-05-11
CN101938989B (zh) 2012-07-11
TWI337876B (pt) 2011-03-01
KR101047242B1 (ko) 2011-07-06
US20120134944A1 (en) 2012-05-31
JPWO2009099194A1 (ja) 2011-05-26
US8426435B2 (en) 2013-04-23
EP2250998B1 (en) 2016-04-13
EP3067038B1 (en) 2017-10-11
KR101039220B1 (ko) 2011-06-03
TWI381856B (zh) 2013-01-11
US8563552B2 (en) 2013-10-22
US20100316584A1 (en) 2010-12-16
EP2250999A4 (en) 2011-05-11
TW200938226A (en) 2009-09-16
WO2009099192A1 (ja) 2009-08-13
KR20100120150A (ko) 2010-11-12
TW200938229A (en) 2009-09-16
EP3067038A1 (en) 2016-09-14
US20110003817A1 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
BRPI0908143A2 (pt) Agente de branqueamento e preparação externa da pele
BRPI0917378A2 (pt) tratamento da transpiracao e da hiperidrose
BRPI0910874A2 (pt) composições e métodos para cuidado da pele
BRPI0819361A2 (pt) Composição de tratamento de cabelos e agente de tratamento
BR112013009792A2 (pt) composição detergente que compreende agente de azulamento e alvejante rapidamente soluvel em agua
BR112012002536A2 (pt) rejuvenescimento da pele cosmético
BRPI0913574A2 (pt) composição de tratamento de acne compreendendo nanoprata e usos
BR112013002642A2 (pt) método de preparo de um enxerto de pele e método de aplicação de enxerto de pele
BRPI0812264A2 (pt) Vesícula, e, preparação externa para pele
BRPI0911656A2 (pt) formulações de nanopartículas e usos das mesmas
BR112013002644A2 (pt) método de enxertia de pele e método de tratamento de vitiligo
EP2400916A4 (en) DENTAL AND MEDICAL TREATMENTS AND METHOD
BRPI0909251A2 (pt) Composição para o cuidado da pele
BRPI1013486A2 (pt) composições aquosas de limpeza de cabelos e pele
BRPI0716592A2 (pt) Composição para cuidado da pele
BRPI0920030A2 (pt) agente de oclusão do tecido
BR112013013311A2 (pt) agente terapêutico de indução de citotoxicidade
BRPI0907918A2 (pt) Ácidos sulfoperoxicarxílicos, sua preparação e métodos de utilizção como agentes alvejantes e antimicrobianos
BRPI0919150A2 (pt) aplicadores de fluxo de ar e métodos de tratamento relacionados
BRPI0921303A2 (pt) agente redutor de rugas, composto, e, preparação externa para a pele.
ES2614941T8 (es) Dispositivo de agente de revestimiento y dispositivo de revestimiento
BRPI0912134A2 (pt) preparação externa para pele
BRPI0907109A2 (pt) lenço dental e método
BRPI0821720A2 (pt) Aplicação de líquidos iônicos, magnéticos como agente de extração
BR112013012586A2 (pt) composição cosmética para o branqueamento da pele compreendendo resveratrol

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/02/2009, OBSERVADAS AS CONDICOES LEGAIS.